1. Home
  2. LEGN vs URBN Comparison

LEGN vs URBN Comparison

Compare LEGN & URBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • URBN
  • Stock Information
  • Founded
  • LEGN 2014
  • URBN 1970
  • Country
  • LEGN United States
  • URBN United States
  • Employees
  • LEGN N/A
  • URBN N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • URBN Clothing/Shoe/Accessory Stores
  • Sector
  • LEGN Health Care
  • URBN Consumer Discretionary
  • Exchange
  • LEGN Nasdaq
  • URBN Nasdaq
  • Market Cap
  • LEGN 5.9B
  • URBN 6.1B
  • IPO Year
  • LEGN 2020
  • URBN 1993
  • Fundamental
  • Price
  • LEGN $29.60
  • URBN $61.44
  • Analyst Decision
  • LEGN Strong Buy
  • URBN Buy
  • Analyst Count
  • LEGN 13
  • URBN 11
  • Target Price
  • LEGN $72.92
  • URBN $81.09
  • AVG Volume (30 Days)
  • LEGN 1.3M
  • URBN 2.0M
  • Earning Date
  • LEGN 11-12-2025
  • URBN 11-18-2025
  • Dividend Yield
  • LEGN N/A
  • URBN N/A
  • EPS Growth
  • LEGN N/A
  • URBN 55.85
  • EPS
  • LEGN N/A
  • URBN 5.10
  • Revenue
  • LEGN $909,045,000.00
  • URBN $5,832,231,000.00
  • Revenue This Year
  • LEGN $68.68
  • URBN $12.62
  • Revenue Next Year
  • LEGN $48.49
  • URBN $6.93
  • P/E Ratio
  • LEGN N/A
  • URBN $12.04
  • Revenue Growth
  • LEGN 74.75
  • URBN 9.63
  • 52 Week Low
  • LEGN $27.34
  • URBN $36.48
  • 52 Week High
  • LEGN $45.30
  • URBN $80.71
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 30.03
  • URBN 37.73
  • Support Level
  • LEGN $29.92
  • URBN $60.14
  • Resistance Level
  • LEGN $33.50
  • URBN $63.80
  • Average True Range (ATR)
  • LEGN 1.31
  • URBN 2.35
  • MACD
  • LEGN -0.21
  • URBN -0.04
  • Stochastic Oscillator
  • LEGN 7.78
  • URBN 21.31

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About URBN Urban Outfitters Inc.

Founded in 1970, Philadelphia-based Urban Outfitters is an apparel and home goods retailer that operates more than 700 stores and e-commerce in the United States, which accounts for about 87% of sales, and other regions. Its retail nameplates are Urban Outfitters (23% of fiscal 2025 sales), Free People/Movement (26%), and Anthropologie (44%). Retail accounted for 88% of fiscal 2025 revenue, but Urban Outfitters also sells products through a wholesale operation, owns some restaurants, and operates a fast-growing clothing rental and resale business called Nuuly (7% of sales). Urban Outfitters primarily markets to young adults and offers products in categories such as apparel (66% of sales), home goods (16% of sales), accessories (13% of sales), and more.

Share on Social Networks: